Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 86

1.

CD97 is a multifunctional leukocyte receptor with distinct roles in human cancers (Review).

Safaee M, Clark AJ, Ivan ME, Oh MC, Bloch O, Sun MZ, Oh T, Parsa AT.

Int J Oncol. 2013 Nov;43(5):1343-50. doi: 10.3892/ijo.2013.2075. Epub 2013 Aug 22. Review.

PMID:
23969601
2.

Overexpression of CD97 confers an invasive phenotype in glioblastoma cells and is associated with decreased survival of glioblastoma patients.

Safaee M, Clark AJ, Oh MC, Ivan ME, Bloch O, Kaur G, Sun MZ, Kim JM, Oh T, Berger MS, Parsa AT.

PLoS One. 2013 Apr 26;8(4):e62765. doi: 10.1371/journal.pone.0062765. Print 2013.

3.

Human EMR2, a novel EGF-TM7 molecule on chromosome 19p13.1, is closely related to CD97.

Lin HH, Stacey M, Hamann J, Gordon S, McKnight AJ.

Genomics. 2000 Jul 15;67(2):188-200.

PMID:
10903844
4.

The role of epidermal growth factor-like module containing mucin-like hormone receptor 2 in human cancers.

Safaee M, Ivan ME, Oh MC, Oh T, Sayegh ET, Kaur G, Sun MZ, Bloch O, Parsa AT.

Oncol Rev. 2014 Apr 1;8(1):242. doi: 10.4081/oncol.2014.242. eCollection 2014 Mar 17. Review.

5.

CD97 amplifies LPA receptor signaling and promotes thyroid cancer progression in a mouse model.

Ward Y, Lake R, Martin PL, Killian K, Salerno P, Wang T, Meltzer P, Merino M, Cheng SY, Santoro M, Garcia-Rostan G, Kelly K.

Oncogene. 2013 May 30;32(22):2726-38. doi: 10.1038/onc.2012.301. Epub 2012 Jul 16.

PMID:
22797060
6.

The human EGF-TM7 family member EMR2 is a heterodimeric receptor expressed on myeloid cells.

Kwakkenbos MJ, Chang GW, Lin HH, Pouwels W, de Jong EC, van Lier RA, Gordon S, Hamann J.

J Leukoc Biol. 2002 May;71(5):854-62.

PMID:
11994511
7.

Molecular cloning and structural analysis of the porcine homologue to CD97 antigen.

de la Lastra JM, Shahein YE, Garrido JJ, Llanes D.

Vet Immunol Immunopathol. 2003 Jun 20;93(3-4):107-15.

PMID:
12814696
8.

CD97 is a processed, seven-transmembrane, heterodimeric receptor associated with inflammation.

Gray JX, Haino M, Roth MJ, Maguire JE, Jensen PN, Yarme A, Stetler-Stevenson MA, Siebenlist U, Kelly K.

J Immunol. 1996 Dec 15;157(12):5438-47.

PMID:
8955192
9.

Individual cell-based models of tumor-environment interactions: Multiple effects of CD97 on tumor invasion.

Galle J, Sittig D, Hanisch I, Wobus M, Wandel E, Loeffler M, Aust G.

Am J Pathol. 2006 Nov;169(5):1802-11.

10.

Differential expression of the EGF-TM7 family members CD97 and EMR2 in lipid-laden macrophages in atherosclerosis, multiple sclerosis and Gaucher disease.

van Eijk M, Aust G, Brouwer MS, van Meurs M, Voerman JS, Dijke IE, Pouwels W, Sändig I, Wandel E, Aerts JM, Boot RG, Laman JD, Hamann J.

Immunol Lett. 2010 Apr 8;129(2):64-71. doi: 10.1016/j.imlet.2010.02.004. Epub 2010 Feb 16.

PMID:
20167235
11.

Expression of CD97 and CD55 in human medullary thyroid carcinomas.

Mustafa T, Klonisch T, Hombach-Klonisch S, Kehlen A, Schmutzler C, Koehrle J, Gimm O, Dralle H, Hoang-Vu C.

Int J Oncol. 2004 Feb;24(2):285-94.

PMID:
14719104
12.

CD97 in leukocyte trafficking.

Hamann J, Veninga H, de Groot DM, Visser L, Hofstra CL, Tak PP, Laman JD, Boots AM, van Eenennaam H.

Adv Exp Med Biol. 2010;706:128-37. Review.

PMID:
21618832
13.

Expression of the EGF-TM7 receptor CD97 and its ligand CD55 (DAF) in multiple sclerosis.

Visser L, de Vos AF, Hamann J, Melief MJ, van Meurs M, van Lier RA, Laman JD, Hintzen RQ.

J Neuroimmunol. 2002 Nov;132(1-2):156-63.

PMID:
12417446
14.

LPA receptor heterodimerizes with CD97 to amplify LPA-initiated RHO-dependent signaling and invasion in prostate cancer cells.

Ward Y, Lake R, Yin JJ, Heger CD, Raffeld M, Goldsmith PK, Merino M, Kelly K.

Cancer Res. 2011 Dec 1;71(23):7301-11. doi: 10.1158/0008-5472.CAN-11-2381. Epub 2011 Oct 6.

15.

The epidermal growth factor-seven transmembrane (EGF-TM7) receptor CD97 is required for neutrophil migration and host defense.

Leemans JC, te Velde AA, Florquin S, Bennink RJ, de Bruin K, van Lier RA, van der Poll T, Hamann J.

J Immunol. 2004 Jan 15;172(2):1125-31.

16.

Molecular cloning of bovine CD97: an EGF-TM7 molecule expressed as isoforms.

Eichler W, Stieler JT, Vogel B, Wobus M, Aust G.

Mol Immunol. 2004 Jul;41(8):751-8.

PMID:
15234554
17.

CD97, an adhesion receptor on inflammatory cells, stimulates angiogenesis through binding integrin counterreceptors on endothelial cells.

Wang T, Ward Y, Tian L, Lake R, Guedez L, Stetler-Stevenson WG, Kelly K.

Blood. 2005 Apr 1;105(7):2836-44. Epub 2004 Dec 2.

18.

Identification of the epidermal growth factor-TM7 receptor EMR2 and its ligand dermatan sulfate in rheumatoid synovial tissue.

Kop EN, Kwakkenbos MJ, Teske GJ, Kraan MC, Smeets TJ, Stacey M, Lin HH, Tak PP, Hamann J.

Arthritis Rheum. 2005 Feb;52(2):442-50.

19.

Thy-1 (CD90) is an interacting partner for CD97 on activated endothelial cells.

Wandel E, Saalbach A, Sittig D, Gebhardt C, Aust G.

J Immunol. 2012 Feb 1;188(3):1442-50. doi: 10.4049/jimmunol.1003944. Epub 2011 Dec 30.

20.

Characterization of the CD55 (DAF)-binding site on the seven-span transmembrane receptor CD97.

Hamann J, Stortelers C, Kiss-Toth E, Vogel B, Eichler W, van Lier RA.

Eur J Immunol. 1998 May;28(5):1701-7.

Supplemental Content

Support Center